Based on National development plans, HEC as strategic trusty partner of both private and state audiences provides genomic sequencing services to whole healthcare professionals and researchers with reliable genomic data and genetic testing solutions by most feasible terms. We arrange to provide scientists, healthcare and clinical professionals with precisiongenomic data and relevant solutions, at minimum testing time considering lowest possible prices.
After years of providing genetic testing services under supports of global premium Partners, we invest on building Regional Reference Genome Sequencing Pilots to provide complete array of genomic sequencing solutions with applications in human, plant and animal, and microbial research. HEC facilities would build based on latest next-generation sequencing technologiesin collaboration with leaders of technologyto provide affordable, innovative and reliable solutions for any levels of genomic challenges.
To find presence and measure RNA in a biological sample RNA Sequencing would be done. This Compared to hybridization-based RNA quantification methods such as microarray analysis, sequencing-based transcriptome detection declare gene expression with low background, high accuracy and high levels of reproducibility within a large dynamic range. RNA-Sequencing (Quantification) allows the entire transcriptome to be surveyed in a very high-throughput and quantitative manner at single-base resolution.
Whole genome sequencing:
Basicallymicroarray-based genotyping studies are moving to whole genome sequencing with the significant reduction of costs.in Whole Genome Sequencing, the complete genome sequence at one time would be detectedand most comprehensive collection of an individual’s genetic variation based on the human reference genome, pathogenic and susceptibility genes would be provided.
- Rapid whole Genome Sequencing (RWGS)
- Whole Exome Sequencing (WES) for biopharmaceutical studies
- Target Region Sequencing (TRS)
HECbased on latest achievements of scientists and following precision global guidelines for hereditary risk screening cancer panels targets ongenes linked to a cancerpredisposition.Hereditary Breast and Ovarian “HBOC” panel develop with significant dataon genes associated and detects different alterations including germline SNV, Indels and CNVs.
HEC long presence on Pharmacopeia fields leads to being well prepared for pharma solutions and genome pilot centers are planned to provide ranges of services for:
- Clinical Survey
- Oncology studies
- Immunology Researches
Detecting any disease at an early stage is most important issue and timely medical intervention before more serious and sometimes irreversible health issues are caused.
1000s babies regionally are born with birth defects; many of them appear healthy at birth but come from families with no history of the disorder. Many affected babies are not identified until the appearance of severe and often irreversible symptoms later in life.
With Newborn whole genetic screening we determine baby’s risk for all disorders and customized solutions.